VFA
GNMK

Virtus Fund Advisers’s GenMark Diagnostics, Inc GNMK Stock Holding History

Virtus Fund Advisers’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,550
Closed -$48K – 2187
2014
Q2 		$48K Buy
+3,550
New +$37K ﹤0.01% 1900

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Virtus Fund Advisers's GNMK Position: Q3 2014 in Review

Virtus Fund Advisers sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2014, closing a stake of 3,550 shares — an estimated $48K sold.

Virtus Fund Advisers first reported a position in GNMK in Q2 2014 and held it in 1 quarter. The position peaked at $48K in Q2 2014. 82 funds tracked by Wall St. Rank hold GNMK as of Q3 2014.

  • Virtus Fund Advisers reported no remaining GenMark Diagnostics, Inc position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 3,550 GenMark Diagnostics, Inc shares in Q3 2014, an estimated $48K.
  • Virtus Fund Advisers first reported a position in GenMark Diagnostics, Inc in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's GenMark Diagnostics, Inc position peaked at $48K in Q2 2014.
  • 82 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.